Partners & Investors
Backing the Ventures That Will Define the Future of Healthcare.
At Panacea, we know that transformational innovation doesn’t happen in isolation.
It takes a system—scientists, founders, universities, corporates, charities, governments, and investors—working together to turn deep science into global impact.
We’ve built a platform to make that possible. A venture system that de-risks, accelerates, and unlocks capital—at every stage.
Whether you’re a partner or investor, Panacea offers a path to shape the future of health innovation.
Partners
Strategic by Design. Built to Matter.
Our venture model is built to help partners go beyond sourcing—to shaping.
Together, we translate breakthrough science into investable, scalable companies, aligned to clinical and market needs, focussing on maturing assets all the way to first-in-human.
We operate across three phases.
[Explore our programmes]
Ignite
Opportunity shaping & venture creation
Stride
Scientific & commercial de-risking
Surge
Capital & operational scale-up
Bio-Rad Laboratories has enjoyed a long-standing partnership with Panacea, with a key focus on advancing science together. We are excited to offer our experience to help and support entrepreneurs as they turn their ground-breaking ideas into successful cutting-edge startups around Europe.
— Richard Kurtz, Vice President, Corporate Business Development, Bio-Rad Laboratories
Universities
- Inspire a culture of sci-entrepreneurship among researchers and students
- Translate academic IP into investable startups
- Increase impact, income, and translational success
Corporates in Health & Life Sciences
- Inspire a culture of sci-entrepreneurship among researchers and students
- Translate academic IP into investable startups
- Gain privileged access to the next generation of Bio-AI ventures
.png)
Charities & Research Funders
- Turn funded discoveries into real clinical outcomes
- Create founder pathways and long-term translational ROI
- Scale impact while staying mission-aligned
.png)
Government & Public Sector
- Build regional venture ecosystems from lab to Series A+
- Close translational gaps with trusted execution partners
- Position your region as a hub for Bio-AI innovation
.png)
Service Providers
- Gain early access to curated deal flow
- Build relationships with future category leaders
- Offer strategic mentorship that converts to long-term clients
The BHF is delighted to partner with Panacea Innovation to roll out CardioStars, a bespoke educational programme to equip cardiovascular scientists with the knowledge, skills and networks to enable translation of research discoveries for patient benefit.
—James Leiper, Director of Research, British Heart Foundation
Investors
Capitalising on Healthcare’s Next Frontier
We don’t just produce startups.
We engineer companies of consequence—clinically credible, commercially viable, and capital-efficient from the outset.
All investment activity is managed by Panacea Capital our dedicated VC arm.
Through Panacea Capital, you can invest early in ventures shaped for scale, access deal flow across Pre-Seed, Seed, and Series A, co-invest alongside global healthcare leaders and back the next generation of Bio-AI convergence companies.
[visit panacea capital]
The ventures emerging from Panacea are among the highest-quality early-stage healthtech opportunities we've seen—de-risked, credible, and capital-ready.
— Healthcare VC Partner, London
Demo Days
See the Future First
These invite-only events bring together top-tier investors, partners, and corporates—offering early access to companies poised for clinical and commercial lift-off.
[Join the investors list]
